News
Zentalis Pharmaceuticals To Highlight Preclinical Data Demonstrating That WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-Tumor Activity With KRAS(G12C) Inhibitors At AACR Annual Meeting 2024
2 Apr 24
Biotech, News, General
12 Health Care Stocks Moving In Thursday's After-Market Session
28 Mar 24
Movers
HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $46 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Wedbush Maintains Neutral on Zentalis Pharma, Raises Price Target to $15
28 Feb 24
News, Price Target, Analyst Ratings
Zentalis Pharma FY EPS $(4.47) Up From $(4.48) YoY; Cash Balance Of $483M, With Projected Cash Runway Into 2026
27 Feb 24
Earnings, News
Press releases
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
2 Apr 24
News, Press Releases
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Apr 24
Health Care, Press Releases
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Mar 24
Press Releases
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
27 Feb 24
Earnings, Press Releases
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Feb 24
Press Releases